← Leaderboards
Yingye Zheng
Fred Hutchinson Cancer Research Center
$22,186,215
Attributed
$54,290,392
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.7M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$54,290,392 · 6
By mechanism
U24$48,817,040 · 3
R01$4,453,952 · 2
UH3$1,019,400 · 1
Top collaborators
- Ziding Feng7 shared
- Christopher I Li6 shared
- Ruth D Etzioni4 shared
- Daniel W Lin4 shared
- James Dai3 shared
- Wei Sun3 shared
- William E Barlow2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Ziding Feng$59,366,183
- Christopher I Li$36,171,442
- Ruth D Etzioni$37,666,206
- Mark Thornquist$22,014,177
- Daniel W Lin$11,737,232
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationProceduresResearch PersonnelMalignant NeoplasmsMonitorValidation StudiesStatistical MethodsBiological MarkersProgramsProspectiveDesignEarly Detection Research NetworkValidationComputer SoftwareIndolentBaseCaringCollaborationsPerformanceAlgorithmsCancer BiomarkersBiomarker EvaluationData SharingEarly Diagnosis
Grant awards (35)
The Early Detection Research Network: Data Management and Coordinating Center$9,121,071
U24 · FY2025 · CA · contact PI
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit$792,000
U24 · FY2025 · CA · contact PI
The Early Detection Research Network: Data Management and Coordinating Center$8,752,632
U24 · FY2024 · CA · contact PI
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit$752,400
U24 · FY2024 · CA · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$74,085
R01 · FY2024 · CA · contact PI
The Early Detection Research Network: Data Management and Coordinating Center$8,841,413
U24 · FY2023 · CA · contact PI
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit$792,000
U24 · FY2023 · CA · contact PI
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$642,698
U24 · FY2023 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$423,294
R01 · FY2023 · CA · contact PI
The Early Detection Research Network: Data Management and Coordinating Center$7,273,306
U24 · FY2022 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$822,171
U24 · FY2022 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$235,567
R01 · FY2022 · CA · contact PI
The Early Detection Research Network: Data Management and Coordinating Center$1,333,448
U24 · FY2021 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$743,093
U24 · FY2021 · CA
The Early Detection Research Network: Data Management and Coordinating Center$739,346
U24 · FY2021 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$370,826
R01 · FY2021 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$194,491
UH3 · FY2021 · CA
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$131,912
UH3 · FY2021 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$1
R01 · FY2021 · CA · contact PI
The Early Detection Research Network: Data Management and Coordinating Center$4,684,501
U24 · FY2020 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$1,156,938
U24 · FY2020 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$370,827
R01 · FY2020 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$327,141
UH3 · FY2020 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$1,152,820
U24 · FY2019 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$389,827
R01 · FY2019 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$365,856
UH3 · FY2019 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)$1,217,203
U24 · FY2018 · CA
Statistical Methods for Prospective Evaluation of Biomarkers$311,112
R01 · FY2017 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$311,112
R01 · FY2016 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$311,112
R01 · FY2015 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$326,324
R01 · FY2014 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$324,351
R01 · FY2012 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$324,952
R01 · FY2011 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$328,824
R01 · FY2010 · GM · contact PI
Statistical Methods for Prospective Evaluation of Biomarkers$351,738
R01 · FY2009 · GM · contact PI